Global Insulin Pumps Market to Reach $17.8 Billion by 2030
The global market for Insulin Pumps estimated at US$10.1 Billion in the year 2022, is projected to reach a revised size of US$17.8 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2022-2030. Tethered Pumps, one of the segments analyzed in the report, is projected to record 6.8% CAGR and reach US$13.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Patch Pumps segment is readjusted to a revised 9% CAGR for the next 8-year period.The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 6.9% CAGR
The Insulin Pumps market in the U.S. is estimated at US$3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.1 Billion by the year 2030 trailing a CAGR of 6.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 6.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.7% CAGR.Select Competitors (Total 12 Featured) -
- Debiotech S.A.
- F. Hoffmann-La Roche Ltd.
- Insulet Corp.
- Medtronic Plc.
- Sooil Development Co. Ltd.
- Tandem Diabetes Care Inc.
- Valeritas Inc.
- Ypsomed Holding AG
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYREST OF EUROPEREST OF WORLDIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Debiotech S.A.
- F. Hoffmann-La Roche Ltd.
- Insulet Corp.
- Medtronic Plc.
- Sooil Development Co. Ltd.
- Tandem Diabetes Care Inc.
- Valeritas Inc.
- Ypsomed Holding AG
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 258 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 10.1 Billion |
Forecasted Market Value ( USD | $ 17.8 Billion |
Compound Annual Growth Rate | 7.3% |
Regions Covered | Global |